-
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- September 2008
- August 2008
- July 2008
-
Meta
Tag Archives: active cellular immunotherapy
Dendreon Gets FDA Approval for Prostate Cancer Fighting Provenge, Stock Leaps
Huge news for Seattle based Dendreon (NASDAQ: DNDN) – the US Food and Drug Administration has finally approved Provenge (Sipuleucel-T) [...]
Dendreon Stock Continues to Climb, Prostate Just the First Cancer On the List
It’s been almost a year since we covered Dendreon announcing its successful Phase III clinical trials for its prostate treatment [...]
Posted in Longevity And Health
Tagged ACI, active cellular immunotherapy, dendreon, immune system, lapuleucel-T, provenge, sipuleucel-T, stock prices
27 Comments